ARCHIVES

Berlin, DeVita Differ On Use Of L-PAM

This article is from The Cancer Letter archive.

Vol. 01 No. 40 | November 8, 1974

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed

April 5, 1985

NCI selects nanotech centers for funding.

October 14, 2005

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Consensus Conference Suggest Research Required For Advances In Pain Control

May 30, 1986

Control Finally Gets A Leader–Diane Fink–With An In-House Promotion; NCI Says It Will Spend All The Program’s $34 Million

March 1, 1974